Department of Biomedical Engineering and the Institute of Complex Molecular Systems, Orthopaedic Biomechanics, Eindhoven University of Technology, Eindhoven, The Netherlands.
Department for Health Evidence, SYRCLE, Radboud Institute for Health Sciences, Radboudumc, Nijmegen, The Netherlands.
PLoS One. 2021 Nov 4;16(11):e0257724. doi: 10.1371/journal.pone.0257724. eCollection 2021.
Drug research with animal models is expensive, time-consuming and translation to clinical trials is often poor, resulting in a desire to replace, reduce, and refine the use of animal models. One approach to replace and reduce the use of animal models is to use in vitro cell-culture models. To study bone physiology, bone diseases and drugs, many studies have been published using osteoblast-osteoclast co-cultures. The use of osteoblast-osteoclast co-cultures is usually not clearly mentioned in the title and abstract, making it difficult to identify these studies without a systematic search and thorough review. As a result, researchers are all developing their own methods, leading to conceptually similar studies with many methodological differences and, as a consequence, incomparable results. The aim of this study was to systematically review existing osteoblast-osteoclast co-culture studies published up to 6 January 2020, and to give an overview of their methods, predetermined outcome measures (formation and resorption, and ALP and TRAP quantification as surrogate markers for formation and resorption, respectively), and other useful parameters for analysis. Information regarding these outcome measures was extracted and collected in a database, and each study was further evaluated on whether both the osteoblasts and osteoclasts were analyzed using relevant outcome measures. From these studies, additional details on methods, cells and culture conditions were extracted into a second database to allow searching on more characteristics. The two databases presented in this publication provide an unprecedented amount of information on cells, culture conditions and analytical techniques for using and studying osteoblast-osteoclast co-cultures. They allow researchers to identify publications relevant to their specific needs and allow easy validation and comparison with existing literature. Finally, we provide the information and tools necessary for others to use, manipulate and expand the databases for their needs.
动物模型的药物研究既昂贵又耗时,且向临床试验的转化通常效果不佳,因此人们希望用体外细胞培养模型来替代、减少和优化动物模型的使用。替代和减少动物模型使用的一种方法是使用成骨细胞-破骨细胞共培养模型。为了研究骨生理学、骨疾病和药物,许多研究都发表了使用成骨细胞-破骨细胞共培养的文章。在标题和摘要中通常没有明确提及使用成骨细胞-破骨细胞共培养,因此如果不进行系统搜索和彻底审查,很难识别这些研究。结果,研究人员都在开发自己的方法,导致概念上相似的研究有很多方法学差异,因此结果不可比。本研究的目的是系统地综述截至 2020 年 1 月 6 日发表的现有成骨细胞-破骨细胞共培养研究,并概述其方法、预先确定的结局测量指标(形成和吸收,以及碱性磷酸酶和组织蛋白酶 K 定量分别作为形成和吸收的替代标志物),以及其他有用的分析参数。提取并收集有关这些结局测量指标的信息,并将每个研究进一步评估为是否都使用相关结局测量指标来分析成骨细胞和破骨细胞。从这些研究中,将方法、细胞和培养条件的更多详细信息提取到第二个数据库中,以便能够根据更多特征进行搜索。本出版物中呈现的这两个数据库提供了前所未有的关于使用和研究成骨细胞-破骨细胞共培养的细胞、培养条件和分析技术的信息。它们使研究人员能够识别与其特定需求相关的出版物,并允许轻松验证和比较现有文献。最后,我们提供了必要的信息和工具,供其他人根据自己的需求使用、操作和扩展数据库。